Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Auditor change
Credit agrmnt [a]
Director departure
Employment agrmnt
|
|
HORIZON PHARMACEUTICAL LLC (RPTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/26/2016 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Happel David (Chief Commercial Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Smith Michael P (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Gould Ashley C. (Chief Legal Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Smith Julie (President and CEO) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Keltner Llew (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| FRANKLIN RICHARD L (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 6,695 shares
@ $9, valued at
$60.3k
Disposed/sold 8,330 shares
@ $9, valued at
$75k
Disposed/sold 90,000 options to buy
@ $3.54, valued at
$318.6k
Disposed/sold 120,000 options to buy
@ $5.13, valued at
$615.6k
Disposed/sold 50,000 options to buy
@ $5.49, valued at
$274.5k
|
|
| 10/26/2016 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 09/23/2016 |
4
| Gould Ashley C. (Chief Legal Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 06/27/2016 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| Keltner Llew (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| FRANKLIN RICHARD L (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 06/27/2016 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 8,330 shares
@ $0 |
|
| 04/19/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 2,092 shares
@ $0
Granted 7,915 options to buy
@ $5.22, valued at
$41.3k
|
|
| 04/19/2016 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 2,092 shares
@ $0
Granted 7,915 options to buy
@ $5.22, valued at
$41.3k
|
|
| 03/03/2016 |
4
| Happel David (Chief Commerical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Paid exercise price by delivering 576 shares
@ $3.433, valued at
$2k
|
|
| 02/11/2016 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 23,781 shares
@ $0
Granted 89,152 options to buy
@ $3.74, valued at
$333.4k
|
|
| 02/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2016 |
4
| Gould Ashley C. (SVP Gen Counsel-CorpGovernance) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 11,751 shares
@ $0
Granted 44,054 options to buy
@ $3.74, valued at
$164.8k
|
|
| 02/11/2016 |
4
| Smith Michael P (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 22,607 shares
@ $0
Granted 84,751 options to buy
@ $3.74, valued at
$317k
|
|
| 02/11/2016 |
4
| Smith Julie (President and CEO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 64,179 shares
@ $0
Granted 240,595 options to buy
@ $3.74, valued at
$899.8k
|
|
| 09/11/2015 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 09/04/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 09/02/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 07/29/2015 |
4
| Gould Ashley C. (SVP Gen Counsel-CorpGovernance) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 33,252 shares
@ $0
Granted 115,500 options to buy
@ $13.77, valued at
$1.6M
|
|
| 07/02/2015 |
4
| Keltner Llew (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 06/22/2015 |
4
| Daley Thomas E (Chief Business Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
|
|
|